Theratechnologies (NASDAQ:THTX) Trading Down 0.6% – Time to Sell?

Theratechnologies Inc. (NASDAQ:THTX) shares fell 0.6% during mid-day trading on Friday . The stock traded as low as $1.69 and last traded at $1.72. 84,056 shares traded hands during mid-day trading, a decline of 45% from the average session volume of 153,814 shares. The stock had previously closed at $1.73.

Theratechnologies Price Performance

The stock has a market capitalization of $79.09 million, a PE ratio of -17.20 and a beta of 1.30. The stock’s fifty day moving average is $1.54 and its 200-day moving average is $1.40.

Institutional Investors Weigh In On Theratechnologies

A hedge fund recently raised its stake in Theratechnologies stock. Cyndeo Wealth Partners LLC increased its holdings in Theratechnologies Inc. (NASDAQ:THTX) by 26.1% in the third quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 131,311 shares of the company’s stock after purchasing an additional 27,191 shares during the quarter. Cyndeo Wealth Partners LLC owned 0.29% of Theratechnologies worth $163,000 at the end of the most recent reporting period.

About Theratechnologies

Theratechnologies Inc, a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA SV for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with lipodystrophy; and Trogarzo for the treatment of HIV-1 infection in heavily treatment-experienced adults with multidrug-resistant HIV-1 infection failing their current antiretroviral regimen.